Atlas Trials

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

Clinical trial NCT01771107 · COMPLETED

Trial details

NCT number
NCT01771107
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
AIDS-Related Hodgkin LymphomaAnn Arbor Stage II Hodgkin LymphomaAnn Arbor Stage IIA Hodgkin LymphomaAnn Arbor Stage IIB Hodgkin LymphomaAnn Arbor Stage III Hodgkin LymphomaAnn Arbor Stage IIIA Hodgkin LymphomaAnn Arbor Stage IIIB Hodgkin LymphomaAnn Arbor Stage IV Hodgkin LymphomaAnn Arbor Stage IVA Hodgkin LymphomaAnn Arbor Stage IVB Hodgkin LymphomaClassic Hodgkin LymphomaHIV Infection
Start date
2013-03-08
Primary completion
2021-10-15
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.